Swiss Wearable Brand MyKronoz Announces Availability of ZeTime Petite Hybrid Smartwatch at CES 2018
Following a historic crowdfunding campaign raising more than $6 million on Kickstarter and Indiegogo last year, MyKronoz, the premier watchmaking brand for the smart generation, today announced the global availability of its ZeTime Petite hybrid smartwatch. Both ZeTime Petite (39mm) and Regular (44mm) will be on display and available for demos at CES 2018 January 9-12 in Las Vegas.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180104005661/en/
MyKronoz ZeTime Petite & Regular
The world's first hybrid smartwatch with mechanical hands over a color touchscreen, ZeTime offers the classic design of a Swiss timepiece with most advanced features of a smartwatch. MyKronoz’s proprietary ‘Smart Movement’ technology enables ZeTime’s always-on hands to function for up to 30 days with a single charge, ensuring the primary function of the watch – to tell time – is always running. With a retail price starting at $199, the hybrid device is now available in two different sizes (39mm and 44mm) and three collections comprising a variety of watch case finishing and bands, to appeal to a wide audience.
“MyKronoz wants to set a new standard in both the watchmaking and wearable industries. With ZeTime, we have created the first smartwatch with no compromises, bringing the best of Swiss design and expertise into a wearable device” said Boris Brault, CEO and founder of MyKronoz. “As we pursue our ambition to become tomorrow’s leader in new generation of watches with attractive price positioning and innovative technologies, we are beyond excited and proud to present our game-changing product line at CES 2018.”
Proof of its bold and ambitious strategy, MyKronoz ZeTime was supported by more than 35,000 backers, becoming the most funded hybrid smartwatch, the largest campaign ever from a European company and the most backed product of the whole year 2017. Today, ZeTime continues to have an engaged following across online communities and will be massively promoted by early 2018 in retail across more than 60 countries.
Boasting a 1.05-inch TFT color touchscreen for the Petite version, and 1.22-inch for the Regular, MyKronoz is now one of the only wearable brands to offer a smartwatch with two display and case sizes, a key attribute to drive large scale adoption.
ZeTime is packed with advanced, easy-to-use features for any consumer.
Using the color touchscreen and smart crown intuitive navigation, users can control their phone’s functions right from their wrist: read notifications, view incoming calls, check weather forecasts, control music, take a photo, and more. Enhancing the user experience, ZeTime’s proprietary smart movement technology automatically adjusts the hands position to maximize screen visibility when reading notifications content. The hybrid device is also equipped with an optical heart-rate sensor and 3-axis accelerometer to track daily activity and sleep.
Designed to be worn all day everyday, ZeTime is water resistant to ATM 5, comes in a sleek stainless steel watch case, sapphire glass, and a variety of interchangeable bands and customizable watch faces. ZeTime seamlessly connects via Bluetooth with both Android and iOS phones (Android 5.0+ or iOS 8.0 and above).
The MyKronoz ZeTime Petite will be making its debut at CES Unveiled on Sunday January 7, 2018 at Mandalay Bay. ZeTime Petite and the ZeTime Regular hybrid smartwatches will also be on display and available for demos at Pepcom Digital Experience! on Monday, January 8, 2018 at The Mirage; and on the CES 2018 showfloor at the MyKronoz booth in the Sands Expo (Booth #42511) January 9-12, 2018.
Tech Specs (Sizes: [R] Regular – [P] Petite)
- Material: stainless steel, sapphire glass
- Bluetooth: BLE 4.2
- Watch case dimensions: [R] 44 x 12.8 mm – [P] 39 x 12.6 mm
- Watch band dimensions: [R] 22 mm – [P] 18 mm
- Weight: [R] 90g – [P] 80g
- Battery type: Li-iOn [R] 200 mAh – [P] 180 mAh
- Battery life: up to 30 days (analog mode) / 3 days (smartwatch mode)
- Charging system: contact charging
- Display type: TFT Color touchscreen with hole
- Display: [R] 1.22 in / 240*240 px – [P] 1.05 in / 240*240 px
- Sensors: 3-axis accelerometer, optical heart rate
- Water resistance: 5 ATM
- Compatibility: iOS 8+ and Android 5.0+
Founded in January 2013, MyKronoz is a Swiss company based in Geneva that designs and develops wearable devices intended to improve increasingly mobile, connected and digital lifestyles. MyKronoz strives to expand and facilitate the mobile-user experience with stylish, intuitive and functional techcessories. Now present in more than 40 countries, carried by major retailers and partners worldwide: Amazon, Orange, Auchan, Carrefour, Best Buy, Walmart, Yodobashi, HMV, MyKronoz offers a full range of connected devices spanning across 4 product categories: activity trackers, smartwatches, hybrid smartwatches and watch phones. With a unique DNA mixing mobile tech and fashion, MyKronoz’s goal is to cater to the needs and tastes of the world’s most various user types thanks to a full iOS and Android compatibility at an affordable price. For more information, visit www.mykronoz.com or follow @mykronoz on Twitter.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
PSE: APM Forum 2018 Focus on Digitalisation for the Process Industries20.4.2018 15:13 | Pressemelding
At the 2018 Advanced Process Modelling (APM) Forum this week, process industry organisations presented on digital design and operations applications ranging from accelerating development of the next generation of pharmaceuticals to realising millions of dollars per year in increased profit for large process plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005517/en/ Ben Weinstein, head of R&D Product and Process Systems Modeling at Procter & Gamble, delivers the keynote speech on how digital design techniques are used systematically to accelerate innovation in P&G. (Photo: Business Wire) Introducing the conference, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), described the current wave of digitalisation as the culmination of many years of advanced modelling and IT development. “This is a time of extraordinary opportunities for the process industries” he said. Keynote speaker Ma
Aperta Provides Electronic Funds Transfer (EFT) in Cayman Islands20.4.2018 14:01 | Pressemelding
Once again, the Aperta Active Clearing System (ACS) has delivered the mechanism for a country to implement a world-class electronic payment processing environment to maximize a national payments system’s efficiency, effectiveness, security and control. Aperta partnered with the Cayman Islands ACH Operator (Prism Services (Cayman) Ltd.) and local commercial banks to deliver a new Electronic Funds Transfer system. The old process of banks swapping files in a wide-variety of standards and settling bilaterally has been replaced with a common system and standards, employing international-standard secure file transfer protocol, allowing participants to monitor real time net settlement and collateral positions via a secure portal. The Cayman Islands Automated Clearinghouse (CIACH) links all six of the country’s banks and provides the central clearing and settlement mechanism for banks to exchange direct debit and direct credit transactions seamlessly across the country. It is functionally NAC
FII Tech Growth Invests in SECO20.4.2018 13:39 | Pressemelding
FII Tech Growth, a fund managed by Fondo Italiano d’Investimento SGR, announces today its second investment in SECO SpA, one of the European leaders in the embedded electronics market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005413/en/ (Photo: SECO) SECO, headquartered in Arezzo, Tuscany, with subsidiaries in the U.S.A., Germany and Taiwan, was founded in 1979 by entrepreneurs Daniele Conti and Luciano Secciani. The company designs and manufactures micro-computers and integrated systems for industrial applications. With more than 250 employees, SECO supports customers with a worldwide presence such as Cimbali, Esaote, Technogym and Vimar, and generated revenue in excess of Euro 50 million in 2017. The ability to offer innovative solutions by using cutting-edge technologies has allowed SECO to grow steadily over time. The company developed a network of collaborations with universities and research centres La Sapi
Schlumberger Announces First-Quarter 2018 Results20.4.2018 11:05 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the first quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2018 Dec. 31, 2017 Mar. 31, 2017 Sequential Year-on-year Revenue $7,829 $8,179 $6,894 -4% 14% Pretax operating income $974 $1,155 $757 -16% 29% Pretax operating margin 12.4% 14.1% 11.0% -169 bps 145 bps Net income (loss) - GAAP basis $525 $(2,255) $279 n/m 88% Net income, excluding charges & credits* $525 $668 $347 -21% 51% Diluted EPS (loss per share) - GAAP basis $0.38 $(1.63) $0.20 n/m 90% Diluted EPS, excluding charges & credits* $0.38 $0.48 $0.25 -21% 52% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “As forecast, our results in the first quarter of 2018 largely reflected transitory factors, with seasonal reductions in activity in the Northern Hemisphere and planned project startup costs
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases20.4.2018 10:30 | Pressemelding
Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below. Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an appr
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f